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Diffuse intracranial fusiform aneurysmal vasculopathy has been 
described in association with human immunodeficiency virus (HIV) 
infection, although much more frequently in children than in adults. 
This usually presents as either ischaemic or haemorrhagic stroke or 
subarachnoid haemorrhage, but has also been found incidentally. 
Neither the aetiology, nor the treatment of these strokes, is clear. We 
present a case in which the chronological events may shed some light 
on the pathogenesis of HIV-associated vasculopathy and outline the 
current understanding of this complex problem.
Case report
A 22-year-old woman presented with an acute stroke manifesting 
with left hemiparesis and hemineglect. She was HIV-positive with a 
CD4 count of 210/µl and receiving  second-line antiretroviral therapy 
(ART) consisting of tenofovir, lamivudine and Alluvia. She had a 6 
pack year smoking history but had not used any recreational drugs. 
She had no other vascular risk factors for stroke. 
She had first been seen 13 months earlier in June 2010 when she 
was diagnosed with cytomegalovirus (CMV) retinitis and found to be 
HIV infected. A vitreous tap was performed and a polymerase chain 
reaction (PCR) was positive for CMV but negative for varicella zoster 
virus (VZV), herpes simplex virus (HSV)-1 and -2, Toxoplasma 
gondii and Mycobacterium tuberculosis. Her CD4 count was 76/µl. 
She was treated with intravitreous gancyclovir, and ART (lamivudine, 
tenofovir and nevirapine) was started in November 2010. A month 
later a contrast-enhanced computed tomography (CT) brain scan was 
normal apart from generalised cortical atrophy (Fig. 1A). Her CD4 
count had increased to 99/μl, but by January 2011 had deteriorated 
to 20/μl, suggesting non-adherence to therapy. Despite appropriate 
management her vision continued to deteriorate. A repeat vitreous 
tap in April 2011 showed a positive PCR for VZV in addition to CMV 
and she received 2 weeks of intravenous (IV) acyclovir. In July 2011 
her CD4 count was 29/μl and viral load was 2 037 280 RNA cps/ml. 
She admitted non-adherence to ART, possibly because of poor vision. 
Having failed her first ART regimen, she was switched to second-line 
therapy (detailed above).
Three months later she presented with right partial anterior 
circulation stroke. A CT brain scan confirmed a right middle cerebral 
artery territory infarct (not shown). In addition, a CT cerebral 
angiogram demonstrated diffuse fusiform aneurysmal dilatation of all 
vessels of the circle of Willis (Figs 1B and C). A subsequent magnetic 
resonance imaging (MRI) scan confirmed these abnormalities and 
demonstrated additional infarcts in the left posterior globus pallidus 
and right corpus striatum (Fig. 1D). The cerebrospinal fluid (CSF) 
showed an elevated protein (0.98 g/l; normal = 0.15 - 0.45), normal 
glucose (2.6 mmol/l; serum glucose 5.1 mmol/l) with 10 lymphocytes, 
0 polymorphonuclear cells and 5 erythrocytes. The CSF IgG index 
was elevated at 1 (normal <0.7) as was the CSF IgG synthesis rate 
(>100 mg/24 h; normal ≤3.3). The fluorescent treponemal antigen 
(FTA), cryptococcal latex agglutination test (CLAT) and Gram stain 
and culture were all negative. PCR for VZV, HSV-1 and -2 and CMV 
were negative. She was initially treated with empirical IV acyclovir 
but this was discontinued when the PCR for VZV in the CSF proved 
negative. She was started on aspirin and made a significant recovery 
from the stroke although she remained functionally blind as a 
consequence of CMV retinitis.
Discussion
Fusiform aneurysmal vasculopathy has been reported in HIV-infected 
subjects with stroke although the aetiology remains uncertain.1 We 
present a patient with HIV/AIDS who was profoundly immune-
compromised when she presented with CMV retinitis. At that time, 
a contrast-enhanced CT scan showed that her brain (and medium-
sized cerebral vessels) were normal, apart from HIV-associated 
cortical atrophy. Subsequently, she developed evidence of VZV 
(re)activation/replication albeit in the vitreous of the eye, and a 
few months later presented with relatively widespread intracranial 
fusiform aneurysmal vasculopathy complicated by cerebral infarcts. 
The cause of HIV-associated vasculopathy is contentious, but the most 
frequent aetiological considerations are that it is due to varicella zoster 
or to HIV itself. Other causes, such as syphilis, were excluded in this 
patient and CMV has not been associated with aneurysmal vasculitis.2 
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We present a case and discuss stroke related to human 
immunodeficiency virus (HIV) infection and the difficulties 
of reaching a firm diagnosis of the cause of the aneurysmal 
vasculopathy. In the absence of a clear aetiology we suggest looking 
for varicella zoster virus (VZV) replication in the cerebrospinal 
fluid (CSF) by polymerase chain reaction (PCR) and treating with 
intravenous acyclovir, aiming for HIV control with appropriate 
antiretroviral therapy and providing suitable antiplatelet agents. If 
there is a high index of suspicion of VZV, therapy with acyclovir 
may be prudent even if the CSF PCR is negative (as may occur 
after the first 2 weeks of reactivation of infection). Determination 
of a VZV plasma:CSF IgG ratio is not readily available and would 
only provide surrogate support for a previous VZV infection in the 
central nervous system compartment.  
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HIV-associated intracranial fusiform aneurysmal vasculopathy 
was first described in children in the 1980s and over the last 
decade has been increasingly reported in adult patients (n=19).1 
Strokes usually present as a partial anterior circulation infarction, 
but subarachnoid haemorrhages as well as clinical presentations of 
seizures and encephalopathy have been reported.1 Patients typically 
have CD4 counts of <200/μl although cases with higher CD4 counts 
are described. Neuro-imaging shows fusiform dilatation and stenosis 
of multiple intracranial arteries.1 Relatively few cases have come to 
autopsy, but in those where histological examination of the cerebral 
vasculature was possible, there was fragmentation of the internal 
elastic lamina with medial and adventitial fibrosis. Some cases have 
also shown intimal hypertrophy.1,2 These findings are similar to those 
described for VZV and most reports have not systematically excluded 
VZV.3,4 When presence of VZV was investigated it mainly involved 
measuring active viral replication via CSF PCR, which, as discussed 
below, may not always be relevant. Nevertheless, there are several 
cases where VZV antigen was not histologically detected and where 
HIV was identified in the vessel wall by immune-histochemistry 
(anti-gp41) or PCR.1 
Further support for HIV as the direct cause for intracranial 
vasculopathy comes from the fact that HIV causes an extracranial and 
peripheral large-vessel vasculopathy, a finding that is extremely rare 
with VZV.2 This large-vessel vasculopathy shows similar histology to 
the intracranial variant described above. Interestingly, vasculopathy 
is also observed in simian immunodeficiency virus-infected rhesus 
monkeys and in a mouse model of HIV vasculopathy using a 
defective HIV pro-virus.5 The transgenic mice develop a diffuse 
vasculopathy with intimal hypertrophy, primarily a result of smooth-
muscle proliferation, disruption of the elastic lamina and fibrosis of 
the media and adventitia – findings similar to those seen in HIV-
associated vasculopathy.   
Stroke related to recent VZV infection is also well described with 
more than 70 cases reported among children. This association has also 
been observed in adults ,with the largest series containing 30 patients. 
In addition there are 8 separately described cases of VZV with an 
associated aneurysmal vasculopathy.4 Ischaemic or haemorrhagic 
strokes, lacunar infarcts and even multiple strokes in different arterial 
territories have been described with or without associated HIV 
infection. Forty per cent of the paediatric HIV-infected cases had no 
clinical evidence of VZV infection at the time of stroke, which is not 
surprising if the VZV vessel destruction occurred asymptomatically 
previously. It has been suggested that VZV-associated vasculopathy 
is highly likely if the clinical features are accompanied by evidence 
of current CSF VZV infection (positive VZV PCR) or previous 
evidence of VZV replication within the central nervous system (CNS) 
compartment (increased CSF/serum VZV IgG ratio).4 The retina is 
an extension of the CNS, and importantly our case had evidence of 
VZV replication in the vitreous, suggesting that the CNS was exposed 
to the VZV infection.
VZV vasculopathy involves both large and small intracranial 
vessels. The most frequent angiographic abnormalities are 
segmental constriction with poststenotic dilatation. Fusiform 
aneurysmal dilatation is less common.3 Recently Nagel et al.6 
described 3 histologically confirmed cases of stroke due to varicella 
vasculopathy. These were both early (4 weeks after VZV infection) 
and late VZV (48 weeks after infection) vascular presentations and 
showed surprisingly widespread involvement of cerebral vasculature. 
Significantly, in this series, VZV antigen was detected in the 
adventitia of the early biopsy specimen (before acyclovir) and in 
the media and intima of the later case (after treatment of acyclovir), 
suggesting that after VZV reaches the vessel wall via axonal spread, 
it spreads transmurally through vessel walls. 
The persistence of VZV DNA in the vessel wall after a course of 
IV acyclovir as found in a case at postmortem is of concern.4 Some 
cases have been treated with empirical oral valacyclovir following a 
course of IV acyclovir.4 However, most cases of VZV vasculopathy are 
reported to stabilise after treatment.
The difficulty for the clinician lies in distinguishing HIV 
vasculopathy from VZV vasculopathy, and in determining whether 
aneurysmal vasculopathy represents a specific, possibly latent, VZV 
vasculopathy in HIV-infected hosts. Although the development of 
aneurysmal vasculopathy in our patient was temporally associated 
with VZV reactivation in the CNS, HIV replication was also 
uncontrolled. It is possible that an HIV-infected individual with VZV 
vasculopathy is at greater risk of developing the aneurysmal form of 
vasculopathy. An additional intriguing feature of our case is that she 
presented with stroke at a time when systemic immune reconstitution 
had occurred. 
In conclusion, this case highlights some of the difficulties 
associated with identifying the cause of aneurysmal vasculopathy 
in an HIV-infected individual. In the absence of a clear aetiology we 
suggest looking for VZV replication in the CSF by PCR and treating 
with IV acyclovir, aiming for HIV control with appropriate ART 
and providing suitable antiplatelet agents. If there is a high index 
of suspicion of VZV, therapy with acyclovir may be prudent even 
Fig. 1. (A) Contrast-enhanced CT brain scan (3/12/2010) at the level of the 
circle of Willis showing bilateral normal calibre middle cerebral arteries. 
(B) CT cerebral angiogram (CTA) source image 3D MIP (5/10/2011) 
demonstrating fusiform aneurysmal dilatation of both right and left middle 
cerebral arteries and left anterior cerebral artery. (C) Volume-rendered 
3D image of the CTA (5/10/2011) showing diffuse fusiform aneurysmal 
vasculopathy of the circle of Willis, vertebral, basilar and left posterior 
communicating arteries. (D) MRI FLAIR (TE 114, TR10 000) demonstrating 
increased signal in the right corpus striatum (with ex vacuo dilatation), 
insular- and peri-sylvian cortices as well as left posterior globus pallidus. 
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if the CSF PCR is negative (as may occur after the first 2 weeks of 
reactivation of infection). It is worth noting that determination of a 
VZV plasma:CSF IgG ratio is not readily available and would only 
provide surrogate support for a previous VZV infection in the CNS 
compartment. 
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